Propensity Matched Study of Outcomes of Teclistamab in relapsed/refractory Multiple Myeloma with Severe Renal Failure: A Multicenter Database Analysis
20260 citationsJournal Article
Field-Weighted Citation Impact: 0.00
Propensity Matched Study of Outcomes of Teclistamab in relapsed/refractory Multiple Myeloma with Severe Renal Failure: A Multicenter Database Analysis | Researchclopedia